Efficacy of melflufen in multiple myeloma with mutated or deleted TP53.

Acs K, Miettinen JJ, Sergeev P, Heckel T, Diao Y, Witt-Mulder K, Thureson M, Bischler T, Huppunen ME, Suvela M, Obermüller J, Munawar U, Slipicevic A, Bargou RC, Lehmann F, Gelius SS, Norin S, Schjesvold F, Sonneveld P, Stühmer T, Heckman CA

Open source

DOI: 10.1186/s40164-025-00729-1
Published: 2025 Dec 23
Container: Experimental hematology & oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40164-025-00729-1,
  title = {Efficacy of melflufen in multiple myeloma with mutated or deleted TP53.},
  author = {Acs K and Miettinen JJ and Sergeev P and Heckel T and Diao Y and Witt-Mulder K and Thureson M and Bischler T and Huppunen ME and Suvela M and Obermüller J and Munawar U and Slipicevic A and Bargou RC and Lehmann F and Gelius SS and Norin S and Schjesvold F and Sonneveld P and Stühmer T and Heckman CA},
  year = {2025},
  journal = {Experimental hematology \& oncology},
  doi = {10.1186/s40164-025-00729-1},
  url = {https://doi.org/10.1186/s40164-025-00729-1}
}

RIS

TY  - JOUR
TI  - Efficacy of melflufen in multiple myeloma with mutated or deleted TP53.
AU  - Acs K
AU  - Miettinen JJ
AU  - Sergeev P
AU  - Heckel T
AU  - Diao Y
AU  - Witt-Mulder K
AU  - Thureson M
AU  - Bischler T
AU  - Huppunen ME
AU  - Suvela M
AU  - Obermüller J
AU  - Munawar U
AU  - Slipicevic A
AU  - Bargou RC
AU  - Lehmann F
AU  - Gelius SS
AU  - Norin S
AU  - Schjesvold F
AU  - Sonneveld P
AU  - Stühmer T
AU  - Heckman CA
PY  - 2025
JO  - Experimental hematology & oncology
DO  - 10.1186/s40164-025-00729-1
UR  - https://doi.org/10.1186/s40164-025-00729-1
ER  -

APA

K, A., JJ, M., P, S., T, H., Y, D., K, W., M, T., T, B., ME, H., M, S., J, O., U, M., A, S., RC, B., F, L., SS, G., S, N., F, S., P, S., T, S., & CA, H. (2025). Efficacy of melflufen in multiple myeloma with mutated or deleted TP53.. Experimental hematology & oncology. https://doi.org/10.1186/s40164-025-00729-1

Source records

pubmed · retrieved 2026-09-27T15:10:09.052Z